Evaluating candidate medications for central nervous system disorders with specialized services
We apply expertise in behavioral pharmacology to design in vivo models to evaluate therapeutic efficacy and side effect profiles of candidate medications. Through this process, our scientists help clients develop safe and effective medications to treat disorders of the central nervous system.
Using a personalized approach, we collaborate with internal and external investigators and work with clients to design and conduct behavioral studies consistent with their goals. Our team evaluates structure-activity relationship and therapeutic efficacy of novel compounds for drug development, with a specialty in substance abuse liability assessment.
Meet the Experts
View All Experts
Jeffrey Ambroso
Stephen Edwards
Joëlla W. Adams
Felicia Browne
Julie A. Marusich
Josephine A. Mauskopf
Related Projects
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
Read More about Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound
